LARIMAR THERAPEUTICS, INC. Earnings Per Share (Basic)
LARIMAR THERAPEUTICS, INC. (LRMR) reported Earnings Per Share (Basic) of -$0.61 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2025-11-05
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.61.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.41.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.46.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2024-09-30 was -$0.24.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$1.32.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$0.84.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.37.
- LARIMAR THERAPEUTICS, INC. earnings per share, basic for fiscal 2021 was -$2.95.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$0.61 10-Q · filed 2025-11-05 | -$1.50 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.41 10-Q · filed 2025-08-14 | -$0.87 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | -$0.46 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | -$1.32 10-K · filed 2025-03-24 | |||
| 2024-09-30 | -$0.24 10-Q · filed 2025-11-05 | -$0.86 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$0.34 10-Q · filed 2025-08-14 | -$0.62 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.27 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | -$0.84 10-K · filed 2025-03-24 | |||
| 2023-09-30 | -$0.21 10-Q · filed 2024-10-30 | -$0.55 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | -$0.19 10-Q · filed 2024-08-08 | -$0.34 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.15 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.37 10-K · filed 2024-03-14 | |||
| 2022-09-30 | -$0.37 10-Q · filed 2023-11-14 | -$1.32 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$0.47 10-Q · filed 2023-08-10 | -$0.96 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$2.95 10-K · filed 2023-03-14 | |||
| 2021-09-30 | -$0.92 10-Q · filed 2022-11-10 | -$2.48 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.79 10-Q · filed 2022-08-11 | -$1.54 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.76 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$3.57 10-K · filed 2022-03-25 | |||
| 2020-09-30 | -$0.64 10-Q · filed 2021-11-12 | -$2.69 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$1.21 10-Q · filed 2021-08-12 | -$2.33 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |